Global Vital organs support systems and Medical Bionics Market
Global Vital organs support systems and Medical Bionics Market

Vital organs support systems and Medical Bionics Comprehensive Study by Type (Artificial Brain, Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Lungs), Application (Disable Cases, Accident Cases), Type of Patient (Infants, Adult, Geriatric, Pediatric), End User (Hospitals, Surgical Centres) Players and Region - Global Market Outlook to 2025

Vital organs support systems and Medical Bionics Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Mar 2020 Edition 224 Pages 212 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Key Players of Vital organs support systems and Medical Bionics Market Study:
Abiomed, Inc (United States), Boston Scientific Corporation (United States), Abbott Laboratories (United States), Asahi Kasei Corporation (Japan), Baxter International Inc (United States), Cochlear Ltd (Australia), Edwards Lifesciences Corporation (United States), Jarvik Heart, Inc (United States), Medtronic Plc (Ireland), Second Sight Medical Products, Inc (United States) and SynCardia Systems LLC (United States)

In the last few years, Global market of Vital organs support systems and Medical Bionics developed rapidly. Major factors driving the market are Increasing Demand In Developed Countries Due To Awareness .

On the basis of product type, the Vital organs support systems and Medical Bionics market is segmented by Artificial Brain, Artificial Heart, Artificial Kidneys, Artificial Liver and Artificial Lungs.

On the basis of applications, the Vital organs support systems and Medical Bionics market is segmented by Disable Cases and Accident Cases.

Recent Industry Highlights:
On 4th February 2020, Abbott granted approval for its in-development Fully Implantable Left Ventricular Assist System (FILVAS). The company has announced approval for its upcoming implant device..

.

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Vital organs support systems and Medical Bionics market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Vital organs support systems and Medical Bionics market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Medical Device Manufacturers, Regulatory bodies, Research Centres, Potential Investors, Clinical research organizations (CROs) and Downstream vendors.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Artificial Brain
  • Artificial Heart
  • Artificial Kidneys
  • Artificial Liver
  • Artificial Lungs
By Application
  • Disable Cases
  • Accident Cases
By Type of Patient
  • Infants
  • Adult
  • Geriatric
  • Pediatric

By End User
  • Hospitals
  • Surgical Centres

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand In Developed Countries Due To Awareness
      • 3.2.2. Growing Research In Artificial Organ Transplantation
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated With Process And Require Ample Time
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness By Celebrities And Social Workers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Vital organs support systems and Medical Bionics, by Type, Application, Type of Patient , End User and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Vital organs support systems and Medical Bionics (Value)
      • 5.2.1. Global Vital organs support systems and Medical Bionics by: Type (Value)
        • 5.2.1.1. Artificial Brain
        • 5.2.1.2. Artificial Heart
        • 5.2.1.3. Artificial Kidneys
        • 5.2.1.4. Artificial Liver
        • 5.2.1.5. Artificial Lungs
      • 5.2.2. Global Vital organs support systems and Medical Bionics by: Application (Value)
        • 5.2.2.1. Disable Cases
        • 5.2.2.2. Accident Cases
      • 5.2.3. Global Vital organs support systems and Medical Bionics by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Surgical Centres
      • 5.2.4. Global Vital organs support systems and Medical Bionics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Vital organs support systems and Medical Bionics (Volume)
      • 5.3.1. Global Vital organs support systems and Medical Bionics by: Type (Volume)
        • 5.3.1.1. Artificial Brain
        • 5.3.1.2. Artificial Heart
        • 5.3.1.3. Artificial Kidneys
        • 5.3.1.4. Artificial Liver
        • 5.3.1.5. Artificial Lungs
      • 5.3.2. Global Vital organs support systems and Medical Bionics by: Application (Volume)
        • 5.3.2.1. Disable Cases
        • 5.3.2.2. Accident Cases
      • 5.3.3. Global Vital organs support systems and Medical Bionics by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Surgical Centres
      • 5.3.4. Global Vital organs support systems and Medical Bionics Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Vital organs support systems and Medical Bionics (Price)
      • 5.4.1. Global Vital organs support systems and Medical Bionics by: Type (Price)
  • 6. Vital organs support systems and Medical Bionics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abiomed, Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Asahi Kasei Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Baxter International Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cochlear Ltd (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Edwards Lifesciences Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Jarvik Heart, Inc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medtronic Plc (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Second Sight Medical Products, Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. SynCardia Systems LLC (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Vital organs support systems and Medical Bionics Sale, by Type, Application, Type of Patient , End User and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Vital organs support systems and Medical Bionics (Value)
      • 7.2.1. Global Vital organs support systems and Medical Bionics by: Type (Value)
        • 7.2.1.1. Artificial Brain
        • 7.2.1.2. Artificial Heart
        • 7.2.1.3. Artificial Kidneys
        • 7.2.1.4. Artificial Liver
        • 7.2.1.5. Artificial Lungs
      • 7.2.2. Global Vital organs support systems and Medical Bionics by: Application (Value)
        • 7.2.2.1. Disable Cases
        • 7.2.2.2. Accident Cases
      • 7.2.3. Global Vital organs support systems and Medical Bionics by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Surgical Centres
      • 7.2.4. Global Vital organs support systems and Medical Bionics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Vital organs support systems and Medical Bionics (Volume)
      • 7.3.1. Global Vital organs support systems and Medical Bionics by: Type (Volume)
        • 7.3.1.1. Artificial Brain
        • 7.3.1.2. Artificial Heart
        • 7.3.1.3. Artificial Kidneys
        • 7.3.1.4. Artificial Liver
        • 7.3.1.5. Artificial Lungs
      • 7.3.2. Global Vital organs support systems and Medical Bionics by: Application (Volume)
        • 7.3.2.1. Disable Cases
        • 7.3.2.2. Accident Cases
      • 7.3.3. Global Vital organs support systems and Medical Bionics by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Surgical Centres
      • 7.3.4. Global Vital organs support systems and Medical Bionics Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Vital organs support systems and Medical Bionics (Price)
      • 7.4.1. Global Vital organs support systems and Medical Bionics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Vital organs support systems and Medical Bionics: by Type(USD Million)
  • Table 2. Vital organs support systems and Medical Bionics Artificial Brain , by Region USD Million (2014-2019)
  • Table 3. Vital organs support systems and Medical Bionics Artificial Heart , by Region USD Million (2014-2019)
  • Table 4. Vital organs support systems and Medical Bionics Artificial Kidneys , by Region USD Million (2014-2019)
  • Table 5. Vital organs support systems and Medical Bionics Artificial Liver , by Region USD Million (2014-2019)
  • Table 6. Vital organs support systems and Medical Bionics Artificial Lungs , by Region USD Million (2014-2019)
  • Table 7. Vital organs support systems and Medical Bionics: by Application(USD Million)
  • Table 8. Vital organs support systems and Medical Bionics Disable Cases , by Region USD Million (2014-2019)
  • Table 9. Vital organs support systems and Medical Bionics Accident Cases , by Region USD Million (2014-2019)
  • Table 10. Vital organs support systems and Medical Bionics: by End User(USD Million)
  • Table 11. Vital organs support systems and Medical Bionics Hospitals , by Region USD Million (2014-2019)
  • Table 12. Vital organs support systems and Medical Bionics Surgical Centres , by Region USD Million (2014-2019)
  • Table 13. South America Vital organs support systems and Medical Bionics, by Country USD Million (2014-2019)
  • Table 14. South America Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 15. South America Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 16. South America Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 17. South America Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 18. Brazil Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 19. Brazil Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 20. Brazil Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 21. Brazil Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 22. Argentina Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 23. Argentina Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 24. Argentina Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 25. Argentina Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 26. Rest of South America Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 27. Rest of South America Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 28. Rest of South America Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 29. Rest of South America Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 30. Asia Pacific Vital organs support systems and Medical Bionics, by Country USD Million (2014-2019)
  • Table 31. Asia Pacific Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 32. Asia Pacific Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 33. Asia Pacific Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 34. Asia Pacific Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 35. China Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 36. China Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 37. China Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 38. China Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 39. Japan Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 40. Japan Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 41. Japan Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 42. Japan Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 43. India Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 44. India Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 45. India Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 46. India Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 47. South Korea Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 48. South Korea Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 49. South Korea Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 50. South Korea Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 51. Taiwan Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 52. Taiwan Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 53. Taiwan Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 54. Taiwan Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 55. Australia Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 56. Australia Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 57. Australia Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 58. Australia Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 59. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 60. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 61. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 62. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 63. Europe Vital organs support systems and Medical Bionics, by Country USD Million (2014-2019)
  • Table 64. Europe Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 65. Europe Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 66. Europe Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 67. Europe Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 68. Germany Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 69. Germany Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 70. Germany Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 71. Germany Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 72. France Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 73. France Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 74. France Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 75. France Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 76. Italy Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 77. Italy Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 78. Italy Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 79. Italy Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 80. United Kingdom Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 81. United Kingdom Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 82. United Kingdom Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 83. United Kingdom Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 84. Netherlands Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 85. Netherlands Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 86. Netherlands Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 87. Netherlands Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 88. Rest of Europe Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 89. Rest of Europe Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 90. Rest of Europe Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 91. Rest of Europe Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 92. MEA Vital organs support systems and Medical Bionics, by Country USD Million (2014-2019)
  • Table 93. MEA Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 94. MEA Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 95. MEA Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 96. MEA Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 97. Middle East Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 98. Middle East Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 99. Middle East Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 100. Middle East Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 101. Africa Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 102. Africa Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 103. Africa Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 104. Africa Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 105. North America Vital organs support systems and Medical Bionics, by Country USD Million (2014-2019)
  • Table 106. North America Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 107. North America Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 108. North America Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 109. North America Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 110. United States Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 111. United States Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 112. United States Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 113. United States Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 114. Canada Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 115. Canada Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 116. Canada Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 117. Canada Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 118. Mexico Vital organs support systems and Medical Bionics, by Type USD Million (2014-2019)
  • Table 119. Mexico Vital organs support systems and Medical Bionics, by Application USD Million (2014-2019)
  • Table 120. Mexico Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2014-2019)
  • Table 121. Mexico Vital organs support systems and Medical Bionics, by End User USD Million (2014-2019)
  • Table 122. Vital organs support systems and Medical Bionics Sales: by Type(K Unit)
  • Table 123. Vital organs support systems and Medical Bionics Sales Artificial Brain , by Region K Unit (2014-2019)
  • Table 124. Vital organs support systems and Medical Bionics Sales Artificial Heart , by Region K Unit (2014-2019)
  • Table 125. Vital organs support systems and Medical Bionics Sales Artificial Kidneys , by Region K Unit (2014-2019)
  • Table 126. Vital organs support systems and Medical Bionics Sales Artificial Liver , by Region K Unit (2014-2019)
  • Table 127. Vital organs support systems and Medical Bionics Sales Artificial Lungs , by Region K Unit (2014-2019)
  • Table 128. Vital organs support systems and Medical Bionics Sales: by Application(K Unit)
  • Table 129. Vital organs support systems and Medical Bionics Sales Disable Cases , by Region K Unit (2014-2019)
  • Table 130. Vital organs support systems and Medical Bionics Sales Accident Cases , by Region K Unit (2014-2019)
  • Table 131. Vital organs support systems and Medical Bionics Sales: by End User(K Unit)
  • Table 132. Vital organs support systems and Medical Bionics Sales Hospitals , by Region K Unit (2014-2019)
  • Table 133. Vital organs support systems and Medical Bionics Sales Surgical Centres , by Region K Unit (2014-2019)
  • Table 134. South America Vital organs support systems and Medical Bionics Sales, by Country K Unit (2014-2019)
  • Table 135. South America Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 136. South America Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 137. South America Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 138. South America Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 139. Brazil Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 140. Brazil Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 141. Brazil Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 142. Brazil Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 143. Argentina Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 144. Argentina Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 145. Argentina Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 146. Argentina Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 147. Rest of South America Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 148. Rest of South America Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 149. Rest of South America Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 150. Rest of South America Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 151. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Country K Unit (2014-2019)
  • Table 152. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 153. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 154. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 155. Asia Pacific Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 156. China Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 157. China Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 158. China Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 159. China Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 160. Japan Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 161. Japan Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 162. Japan Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 163. Japan Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 164. India Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 165. India Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 166. India Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 167. India Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 168. South Korea Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 169. South Korea Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 170. South Korea Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 171. South Korea Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 172. Taiwan Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 173. Taiwan Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 174. Taiwan Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 175. Taiwan Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 176. Australia Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 177. Australia Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 178. Australia Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 179. Australia Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 180. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 181. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 182. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 183. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 184. Europe Vital organs support systems and Medical Bionics Sales, by Country K Unit (2014-2019)
  • Table 185. Europe Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 186. Europe Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 187. Europe Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 188. Europe Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 189. Germany Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 190. Germany Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 191. Germany Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 192. Germany Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 193. France Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 194. France Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 195. France Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 196. France Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 197. Italy Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 198. Italy Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 199. Italy Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 200. Italy Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 201. United Kingdom Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 202. United Kingdom Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 203. United Kingdom Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 204. United Kingdom Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 205. Netherlands Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 206. Netherlands Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 207. Netherlands Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 208. Netherlands Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 209. Rest of Europe Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 210. Rest of Europe Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 211. Rest of Europe Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 212. Rest of Europe Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 213. MEA Vital organs support systems and Medical Bionics Sales, by Country K Unit (2014-2019)
  • Table 214. MEA Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 215. MEA Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 216. MEA Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 217. MEA Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 218. Middle East Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 219. Middle East Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 220. Middle East Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 221. Middle East Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 222. Africa Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 223. Africa Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 224. Africa Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 225. Africa Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 226. North America Vital organs support systems and Medical Bionics Sales, by Country K Unit (2014-2019)
  • Table 227. North America Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 228. North America Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 229. North America Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 230. North America Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 231. United States Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 232. United States Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 233. United States Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 234. United States Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 235. Canada Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 236. Canada Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 237. Canada Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 238. Canada Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 239. Mexico Vital organs support systems and Medical Bionics Sales, by Type K Unit (2014-2019)
  • Table 240. Mexico Vital organs support systems and Medical Bionics Sales, by Application K Unit (2014-2019)
  • Table 241. Mexico Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2014-2019)
  • Table 242. Mexico Vital organs support systems and Medical Bionics Sales, by End User K Unit (2014-2019)
  • Table 243. Vital organs support systems and Medical Bionics: by Type(USD/Units)
  • Table 244. Company Basic Information, Sales Area and Its Competitors
  • Table 245. Company Basic Information, Sales Area and Its Competitors
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Vital organs support systems and Medical Bionics: by Type(USD Million)
  • Table 256. Vital organs support systems and Medical Bionics Artificial Brain , by Region USD Million (2020-2025)
  • Table 257. Vital organs support systems and Medical Bionics Artificial Heart , by Region USD Million (2020-2025)
  • Table 258. Vital organs support systems and Medical Bionics Artificial Kidneys , by Region USD Million (2020-2025)
  • Table 259. Vital organs support systems and Medical Bionics Artificial Liver , by Region USD Million (2020-2025)
  • Table 260. Vital organs support systems and Medical Bionics Artificial Lungs , by Region USD Million (2020-2025)
  • Table 261. Vital organs support systems and Medical Bionics: by Application(USD Million)
  • Table 262. Vital organs support systems and Medical Bionics Disable Cases , by Region USD Million (2020-2025)
  • Table 263. Vital organs support systems and Medical Bionics Accident Cases , by Region USD Million (2020-2025)
  • Table 264. Vital organs support systems and Medical Bionics: by End User(USD Million)
  • Table 265. Vital organs support systems and Medical Bionics Hospitals , by Region USD Million (2020-2025)
  • Table 266. Vital organs support systems and Medical Bionics Surgical Centres , by Region USD Million (2020-2025)
  • Table 267. South America Vital organs support systems and Medical Bionics, by Country USD Million (2020-2025)
  • Table 268. South America Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 269. South America Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 270. South America Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 271. South America Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 272. Brazil Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 273. Brazil Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 274. Brazil Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 275. Brazil Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 276. Argentina Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 277. Argentina Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 278. Argentina Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 279. Argentina Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 280. Rest of South America Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 281. Rest of South America Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 282. Rest of South America Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 283. Rest of South America Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 284. Asia Pacific Vital organs support systems and Medical Bionics, by Country USD Million (2020-2025)
  • Table 285. Asia Pacific Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 286. Asia Pacific Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 287. Asia Pacific Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 288. Asia Pacific Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 289. China Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 290. China Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 291. China Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 292. China Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 293. Japan Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 294. Japan Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 295. Japan Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 296. Japan Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 297. India Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 298. India Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 299. India Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 300. India Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 301. South Korea Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 302. South Korea Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 303. South Korea Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 304. South Korea Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 305. Taiwan Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 306. Taiwan Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 307. Taiwan Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 308. Taiwan Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 309. Australia Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 310. Australia Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 311. Australia Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 312. Australia Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 313. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 314. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 315. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 316. Rest of Asia-Pacific Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 317. Europe Vital organs support systems and Medical Bionics, by Country USD Million (2020-2025)
  • Table 318. Europe Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 319. Europe Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 320. Europe Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 321. Europe Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 322. Germany Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 323. Germany Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 324. Germany Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 325. Germany Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 326. France Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 327. France Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 328. France Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 329. France Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 330. Italy Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 331. Italy Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 332. Italy Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 333. Italy Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 334. United Kingdom Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 335. United Kingdom Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 336. United Kingdom Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 337. United Kingdom Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 338. Netherlands Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 339. Netherlands Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 340. Netherlands Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 341. Netherlands Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 342. Rest of Europe Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 343. Rest of Europe Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 344. Rest of Europe Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 345. Rest of Europe Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 346. MEA Vital organs support systems and Medical Bionics, by Country USD Million (2020-2025)
  • Table 347. MEA Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 348. MEA Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 349. MEA Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 350. MEA Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 351. Middle East Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 352. Middle East Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 353. Middle East Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 354. Middle East Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 355. Africa Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 356. Africa Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 357. Africa Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 358. Africa Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 359. North America Vital organs support systems and Medical Bionics, by Country USD Million (2020-2025)
  • Table 360. North America Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 361. North America Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 362. North America Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 363. North America Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 364. United States Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 365. United States Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 366. United States Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 367. United States Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 368. Canada Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 369. Canada Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 370. Canada Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 371. Canada Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 372. Mexico Vital organs support systems and Medical Bionics, by Type USD Million (2020-2025)
  • Table 373. Mexico Vital organs support systems and Medical Bionics, by Application USD Million (2020-2025)
  • Table 374. Mexico Vital organs support systems and Medical Bionics, by Type of Patient USD Million (2020-2025)
  • Table 375. Mexico Vital organs support systems and Medical Bionics, by End User USD Million (2020-2025)
  • Table 376. Vital organs support systems and Medical Bionics Sales: by Type(K Unit)
  • Table 377. Vital organs support systems and Medical Bionics Sales Artificial Brain , by Region K Unit (2020-2025)
  • Table 378. Vital organs support systems and Medical Bionics Sales Artificial Heart , by Region K Unit (2020-2025)
  • Table 379. Vital organs support systems and Medical Bionics Sales Artificial Kidneys , by Region K Unit (2020-2025)
  • Table 380. Vital organs support systems and Medical Bionics Sales Artificial Liver , by Region K Unit (2020-2025)
  • Table 381. Vital organs support systems and Medical Bionics Sales Artificial Lungs , by Region K Unit (2020-2025)
  • Table 382. Vital organs support systems and Medical Bionics Sales: by Application(K Unit)
  • Table 383. Vital organs support systems and Medical Bionics Sales Disable Cases , by Region K Unit (2020-2025)
  • Table 384. Vital organs support systems and Medical Bionics Sales Accident Cases , by Region K Unit (2020-2025)
  • Table 385. Vital organs support systems and Medical Bionics Sales: by End User(K Unit)
  • Table 386. Vital organs support systems and Medical Bionics Sales Hospitals , by Region K Unit (2020-2025)
  • Table 387. Vital organs support systems and Medical Bionics Sales Surgical Centres , by Region K Unit (2020-2025)
  • Table 388. South America Vital organs support systems and Medical Bionics Sales, by Country K Unit (2020-2025)
  • Table 389. South America Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 390. South America Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 391. South America Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 392. South America Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 393. Brazil Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 394. Brazil Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 395. Brazil Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 396. Brazil Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 397. Argentina Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 398. Argentina Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 399. Argentina Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 400. Argentina Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 401. Rest of South America Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 402. Rest of South America Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 403. Rest of South America Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 404. Rest of South America Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 405. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Country K Unit (2020-2025)
  • Table 406. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 407. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 408. Asia Pacific Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 409. Asia Pacific Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 410. China Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 411. China Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 412. China Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 413. China Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 414. Japan Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 415. Japan Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 416. Japan Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 417. Japan Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 418. India Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 419. India Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 420. India Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 421. India Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 422. South Korea Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 423. South Korea Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 424. South Korea Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 425. South Korea Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 426. Taiwan Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 427. Taiwan Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 428. Taiwan Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 429. Taiwan Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 430. Australia Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 431. Australia Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 432. Australia Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 433. Australia Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 434. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 435. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 436. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 437. Rest of Asia-Pacific Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 438. Europe Vital organs support systems and Medical Bionics Sales, by Country K Unit (2020-2025)
  • Table 439. Europe Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 440. Europe Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 441. Europe Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 442. Europe Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 443. Germany Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 444. Germany Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 445. Germany Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 446. Germany Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 447. France Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 448. France Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 449. France Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 450. France Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 451. Italy Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 452. Italy Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 453. Italy Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 454. Italy Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 455. United Kingdom Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 456. United Kingdom Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 457. United Kingdom Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 458. United Kingdom Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 459. Netherlands Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 460. Netherlands Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 461. Netherlands Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 462. Netherlands Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 463. Rest of Europe Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 464. Rest of Europe Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 465. Rest of Europe Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 466. Rest of Europe Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 467. MEA Vital organs support systems and Medical Bionics Sales, by Country K Unit (2020-2025)
  • Table 468. MEA Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 469. MEA Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 470. MEA Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 471. MEA Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 472. Middle East Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 473. Middle East Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 474. Middle East Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 475. Middle East Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 476. Africa Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 477. Africa Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 478. Africa Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 479. Africa Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 480. North America Vital organs support systems and Medical Bionics Sales, by Country K Unit (2020-2025)
  • Table 481. North America Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 482. North America Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 483. North America Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 484. North America Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 485. United States Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 486. United States Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 487. United States Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 488. United States Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 489. Canada Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 490. Canada Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 491. Canada Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 492. Canada Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 493. Mexico Vital organs support systems and Medical Bionics Sales, by Type K Unit (2020-2025)
  • Table 494. Mexico Vital organs support systems and Medical Bionics Sales, by Application K Unit (2020-2025)
  • Table 495. Mexico Vital organs support systems and Medical Bionics Sales, by Type of Patient K Unit (2020-2025)
  • Table 496. Mexico Vital organs support systems and Medical Bionics Sales, by End User K Unit (2020-2025)
  • Table 497. Vital organs support systems and Medical Bionics: by Type(USD/Units)
  • Table 498. Research Programs/Design for This Report
  • Table 499. Key Data Information from Secondary Sources
  • Table 500. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Vital organs support systems and Medical Bionics: by Type USD Million (2014-2019)
  • Figure 5. Global Vital organs support systems and Medical Bionics: by Application USD Million (2014-2019)
  • Figure 6. Global Vital organs support systems and Medical Bionics: by End User USD Million (2014-2019)
  • Figure 7. South America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 8. Asia Pacific Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 9. Europe Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 10. MEA Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 11. North America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 12. Global Vital organs support systems and Medical Bionics: by Type K Unit (2014-2019)
  • Figure 13. Global Vital organs support systems and Medical Bionics: by Application K Unit (2014-2019)
  • Figure 14. Global Vital organs support systems and Medical Bionics: by End User K Unit (2014-2019)
  • Figure 15. South America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 16. Asia Pacific Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 17. Europe Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 18. MEA Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 19. North America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 20. Global Vital organs support systems and Medical Bionics: by Type USD/Units (2014-2019)
  • Figure 21. Global Vital organs support systems and Medical Bionics share by Players 2019 (%)
  • Figure 22. Global Vital organs support systems and Medical Bionics share by Players (Top 3) 2019(%)
  • Figure 23. Global Vital organs support systems and Medical Bionics share by Players (Top 5) 2019(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abiomed, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abiomed, Inc (United States) Revenue: by Geography 2019
  • Figure 27. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Boston Scientific Corporation (United States) Revenue: by Geography 2019
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2019
  • Figure 31. Asahi Kasei Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Asahi Kasei Corporation (Japan) Revenue: by Geography 2019
  • Figure 33. Baxter International Inc (United States) Revenue, Net Income and Gross profit
  • Figure 34. Baxter International Inc (United States) Revenue: by Geography 2019
  • Figure 35. Cochlear Ltd (Australia) Revenue, Net Income and Gross profit
  • Figure 36. Cochlear Ltd (Australia) Revenue: by Geography 2019
  • Figure 37. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2019
  • Figure 39. Jarvik Heart, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 40. Jarvik Heart, Inc (United States) Revenue: by Geography 2019
  • Figure 41. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Medtronic Plc (Ireland) Revenue: by Geography 2019
  • Figure 43. Second Sight Medical Products, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 44. Second Sight Medical Products, Inc (United States) Revenue: by Geography 2019
  • Figure 45. SynCardia Systems LLC (United States) Revenue, Net Income and Gross profit
  • Figure 46. SynCardia Systems LLC (United States) Revenue: by Geography 2019
  • Figure 47. Global Vital organs support systems and Medical Bionics: by Type USD Million (2020-2025)
  • Figure 48. Global Vital organs support systems and Medical Bionics: by Application USD Million (2020-2025)
  • Figure 49. Global Vital organs support systems and Medical Bionics: by End User USD Million (2020-2025)
  • Figure 50. South America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 51. Asia Pacific Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 52. Europe Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 53. MEA Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 54. North America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 55. Global Vital organs support systems and Medical Bionics: by Type K Unit (2020-2025)
  • Figure 56. Global Vital organs support systems and Medical Bionics: by Application K Unit (2020-2025)
  • Figure 57. Global Vital organs support systems and Medical Bionics: by End User K Unit (2020-2025)
  • Figure 58. South America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 59. Asia Pacific Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 60. Europe Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 61. MEA Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 62. North America Vital organs support systems and Medical Bionics Share (%), by Country
  • Figure 63. Global Vital organs support systems and Medical Bionics: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Abiomed, Inc (United States)
  • Boston Scientific Corporation (United States)
  • Abbott Laboratories (United States)
  • Asahi Kasei Corporation (Japan)
  • Baxter International Inc (United States)
  • Cochlear Ltd (Australia)
  • Edwards Lifesciences Corporation (United States)
  • Jarvik Heart, Inc (United States)
  • Medtronic Plc (Ireland)
  • Second Sight Medical Products, Inc (United States)
  • SynCardia Systems LLC (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation